United States v. Thomas

939 F.3d 1121
CourtCourt of Appeals for the Tenth Circuit
DecidedOctober 1, 2019
Docket17-1405
StatusPublished
Cited by19 cases

This text of 939 F.3d 1121 (United States v. Thomas) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Thomas, 939 F.3d 1121 (10th Cir. 2019).

Opinion

FILED United States Court of Appeals PUBLISH Tenth Circuit

UNITED STATES COURT OF APPEALS October 1, 2019

Elisabeth A. Shumaker FOR THE TENTH CIRCUIT Clerk of Court _________________________________

UNITED STATES OF AMERICA,

Plaintiff - Appellee, No. 17-1405 v.

DONALD RAY THOMAS, a/k/a Donald Ray Thomas, II,

Defendant - Appellant. _________________________________

Appeal from the United States District Court for the District of Colorado (D.C. No. 1:16-CR-00325-PAB-1) _________________________________

Jacob R. Rasch-Chabot, Assistant Federal Public Defender (Virginia L. Grady, Federal Public Defender, with him on the briefs), Denver, Colorado for Defendant-Appellant.

J. Bishop Grewell, Assistant United States Attorney (Robert C. Troyer, United States Attorney, with him on the brief), Denver, Colorado for Plaintiff-Appellee. _________________________________

Before HARTZ, MATHESON, and EID, Circuit Judges. _________________________________

HARTZ, Circuit Judge. _________________________________

The sole issue presented on this appeal is the meaning of counterfeit substance in

§ 4B1.2(b) of the United States Sentencing Guidelines. Defendant contends that a

counterfeit substance is a controlled substance that has been mislabeled or misbranded fraudulently or without authorization—a definition that appears in a federal statute, 21

U.S.C. § 802(7). The government counters that it is a noncontrolled substance that is

passed off as a controlled substance. Joining the five other circuits that have opined on

the subject, we agree with the government.

Under USSG § 2K2.1(a)(2) the base offense level for a defendant convicted of a

firearm offense is 24 if the offense was committed “subsequent to sustaining at least two

felony convictions of either a crime of violence or controlled substance offense.” The

offense level is 20 if the defendant had a conviction of only one such offense. See id.

§ 2K2.1(a)(4). These provisions adopt the meaning of controlled substance offense in

USSG § 4B1.2(b). See USSG § 2K2.1(a), App. n.1. That definition is as follows:

The term “controlled substance offense” means an offense under federal or state law, punishable by imprisonment for a term exceeding one year, that prohibits the manufacture, import, export, distribution, or dispensing of a controlled substance (or a counterfeit substance) or the possession of a controlled substance (or a counterfeit substance) with intent to manufacture, import, export, distribute, or dispense.

USSG § 4B1.2(b) (emphasis added). The guidelines do not define counterfeit substance

for the purposes of this provision.

Defendant Donald Ray Thomas pleaded guilty in the United States District Court

for the District of Colorado to possession of a firearm by a convicted felon. See 18

U.S.C. § 922(g)(1). On appeal he does not challenge the validity of his plea; but as

permitted by his plea agreement with the government, he raises one challenge with

respect to his sentence. Because it is undisputed that he had a prior felony conviction for

a crime of violence (robbery), his base offense level was at least 20. Whether it was 20

2 or 24 depended on the characterization of his 2014 Colorado conviction of distribution of

an “imitation controlled substance” under Colo. Rev. Stat. § 18-18-422(1)(a). Colorado

defines an imitation controlled substance as:

a substance that is not the controlled substance that it is purported to be but which, by appearance, including color, shape, size, and markings, by representations made, and by consideration of all relevant factors as set forth in section 18-18-421, would lead a reasonable person to believe that the substance is the controlled substance that it is purported to be.

Colo. Rev. Stat. § 18-18-420(3). Defendant challenges the district court’s ruling that his

conviction involved a “counterfeit substance” and therefore was a “controlled substance

offense” under USSG § 2K2.1(a). Exercising jurisdiction under 18 U.S.C. § 3742(a) and

28 U.S.C. § 1291, we reject this challenge and affirm Defendant’s sentence.

I. DISCUSSION

“Ultimately, our task in interpreting the Guidelines is to determine the intent of

the Sentencing Commission.” United States v. Rivera-Oros, 590 F.3d 1123, 1129 (10th

Cir. 2009). We perform this task by applying traditional techniques of statutory

construction. See United States v. Archuleta, 865 F.3d 1280, 1287 (10th Cir. 2017)

(when a term “is not defined in the Guidelines, we must rely on the accepted rules of

statutory construction in defining the term”).

As a general rule, we interpret a word or phrase in a statute or the guidelines in

accordance with its ordinary, everyday meaning. See United States v. Marrufo, 661 F.3d

1204, 1207 (10th Cir. 2011) (“When a term is not defined in the Guidelines, we give it its

plain meaning.”); Antonin Scalia & Brian A. Garner, Reading Law: The Interpretation of

3 Legal Texts, § 6 (“Ordinary-Meaning Canon”) (2012) (“Reading Law”). The definition

of counterfeit in the most authoritative legal dictionary is: “Made to look genuine in an

effort to deceive; produced by fakery, esp. with an intent to defraud.” Black’s Law

Dictionary 427 (10th ed. 2014). This is in keeping with the definitions in leading

dictionaries for general use. See New Oxford American Dictionary 387 (2d ed. 2005)

(“[M]ade in exact imitation of something valuable or important with the intention to

deceive or defraud.”); Webster’s Third New International Dictionary 519 (2002)

(“[M]ade in fraudulent imitation: produced with intent to deceive.”). Thus, a substance

that is not in fact a controlled substance but is passed off as such is commonly referred to

as a counterfeit controlled substance. See, e.g., Franklin v. Bradshaw, 545 F.3d 409, 412

(6th Cir. 2008) (“Hennig realized that they had been given counterfeit cocaine commonly

referred to as ‘fleece.’”); United States v. Martinez, 520 F.3d 749, 751 (7th Cir. 2008)

(“The [drug] agents replaced the cocaine with 100 kilograms of counterfeit cocaine.”);

United States v. Sampson, 140 F.3d 585, 588 (4th Cir. 1998) (two co-conspirators

“testified that . . . they sold ‘flex’ (counterfeit cocaine) to unsuspecting purchasers.”).

The government urges us to use the plain-English definition of counterfeit and construe

counterfeit substance as a substance made in imitation of a controlled substance with

intent to deceive.

Defendant does not contend that if we apply the common meaning of counterfeit

substance, he could nevertheless prevail. He argues, however, that we should adopt a

narrower meaning. He asserts that when determining the meaning of an undefined

offense used in the guidelines, courts have not given the term its ordinary English

4 meaning but have instead looked to federal statutes, state laws, model codes, treatises,

and dictionaries to determine the “generic, contemporary meaning” of the offense. Aplt.

Br. at 11; see United States v. Martinez-Cruz, 836 F.3d 1305, 1309 (10th Cir. 2016) (“To

determine the generic, contemporary meaning of a crime enumerated in the Guidelines,

the court begins by looking to the federal statute under which the defendant was

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Davey
Tenth Circuit, 2025
United States v. Calderon-Padilla
136 F.4th 1270 (Tenth Circuit, 2025)
Mohamed v. Jones
100 F.4th 1214 (Tenth Circuit, 2024)
United States v. Morales-Lopez
92 F.4th 936 (Tenth Circuit, 2024)
United States v. Linares
60 F.4th 1244 (Tenth Circuit, 2023)
Save The Colorado v. Spellmon
50 F.4th 954 (Tenth Circuit, 2022)
Franlink v. BACE Services
50 F.4th 432 (Fifth Circuit, 2022)
United States v. Antwan Heyward
42 F.4th 460 (Fourth Circuit, 2022)
United States v. Hernandez-Calvillo
39 F.4th 1297 (Tenth Circuit, 2022)
United States v. Jones
32 F.4th 1290 (Tenth Circuit, 2022)
United States v. Wilkins
30 F.4th 1198 (Tenth Circuit, 2022)
United States v. Casados
26 F.4th 845 (Tenth Circuit, 2022)
Villegas-Castro v. Garland
19 F.4th 1241 (Tenth Circuit, 2021)
United States v. Maldonado-Passage
4 F.4th 1097 (Tenth Circuit, 2021)
United States v. Benton
988 F.3d 1231 (Tenth Circuit, 2021)
Ramos Avila v. Sessions
D. Colorado, 2020
Banuelos-Galviz v. Barr
953 F.3d 1176 (Tenth Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
939 F.3d 1121, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-thomas-ca10-2019.